cancer weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of cancer weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccine
Manipulating dendritic cell biology provides active immunotherapy of cancer
December 14th, 2004
Manipulating dendritic cell biology provides active immunotherapy of cancer. According to a study from the United States, "Dendritic cells (DCs) are specialized antigen-presenting cells (APCs) that have an unequaled capacity to initiate primary immune responses, including tolerogenic responses. Because of the importance of DCs in the induction and control of immunity, an understanding of their biology is central to the development of potent immunotherapies for cancer, chronic infections, autoimmune disease, and induction of transplantation tolerance." "This review discusses recent advances in DC research and the application of this knowledge toward...
Source: cancer weekly (2004-12-14)
|
